A new measure of patient satisfaction with ocular hypotensive medications: The Treatment Satisfaction Survey for Intraocular Pressure (TSS-IOP)

Health and Quality of Life Outcomes

Volumn 1, Issue , 2003, Pages

  Atkinson, Mark J ^a   Stewart, William C ^b   Fain, Joel M ^c   Stewart, Jeanette A ^d   Dhawan, Ravinder ^c   Mozaffari, Essy ^c   Lohs, Jan ^e  

^a PFIZER INC   (United States)

^b Medical U of South Carolina   (United States)

^c Pfizer Global Pharmaceuticals   (United States)

^d Pharmaceutical Research Network   (United States)

^e Lohs Research Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRIMONIDINE; CARBONATE DEHYDRATASE INHIBITOR; DORZOLAMIDE; PROSTAGLANDIN DERIVATIVE; TIMOLOL MALEATE; ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; BURNING SENSATION; CLINICAL PRACTICE; CONJUNCTIVAL HYPEREMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DISEASE DURATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG USE; DRY EYE; EYE IRRITATION; EYELID DISEASE; FACTORIAL ANALYSIS; FEMALE; HEALTH SURVEY; HUMAN; HYPOTENSION; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; LACRIMAL GLAND DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MONOTHERAPY; NEUROLOGIC DISEASE; OCULAR PRURITUS; OPEN ANGLE GLAUCOMA; OPHTHALMOLOGY; PATIENT SATISFACTION; PHOTOSENSITIVITY; PSYCHOMETRY; QUESTIONNAIRE; RATING SCALE; RELIABILITY; SCORING SYSTEM; SCREENING TEST; SYMPTOM; UNITED STATES; VARIANCE; VISUAL IMPAIRMENT; AGED; DRUG SELF ADMINISTRATION; EPIDEMIOLOGY; GLAUCOMA; INFORMATION PROCESSING; INSTRUMENTATION; MIDDLE AGED; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; STATISTICS; VALIDATION STUDY;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; FACTOR ANALYSIS, STATISTICAL; FOCUS GROUPS; GLAUCOMA; HEALTH CARE SURVEYS; HUMANS; INTRAOCULAR PRESSURE; MIDDLE AGED; OCULAR HYPERTENSION; PATIENT COMPLIANCE; PATIENT SATISFACTION; PSYCHOMETRICS; QUALITATIVE RESEARCH; QUESTIONNAIRES; SELF ADMINISTRATION; UNITED STATES;

EID: 4243156209     PISSN: 14777525     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-7525-1-67     Document Type: Article

References (63)

1. Katz JN: Patient preferences and health disparities. JAMA 2001, 286(12):1506-1509.
2. Owens DK: Spine update. Patient preferences and the development of practice guidelines. Spine 1998, 23(9):1073-1079.
3. Eriksen LR: Patient satisfaction with nursing care: concept clarification. Journal of Nursing Measurement 1995, 3(1):59-76.
4. The Harmonization Meetings Coordination Committee: Report: A decisive step towards the recognition of patient reported outcomes in clinical trials. Proceedings of a Meeting with the FDA: Feb 16, 2001: Important Issues in Patient Reported Outcomes (PROs) Research. QoL Newsletter 2001, 26:24-25.
5. Morris LA and Burke LB: Outcomes research: An FDA perspective. Journal of Research in Pharmaceutical Economics 1996, 8(1):209-213.
6. Burke LB: US regulation of pharmaceutical outcomes research. Value in Health 2001, 4:5-7.
7. Gattellari M, Butow PN and Tattersall MH: Sharing decisions in cancer care. Social Science & Medicine 2001, 52(12):1865-1878.
8. Turnbull JE and Luther KM: Patient satisfaction report paves way to improved care. QRC Advisor 1996, 13(1):1-7.
9. Wright JG: Evaluating the outcome of treatment. Shouldn't We be asking patients if they are better? Journal of Clinical Epidemiology 2000, 53(6):549-553.
10. Brody D, Miller S, Lerman C, Smith D and Caputo G: Patient perception of involvement in medical care: Relationship to illness attitudes and outcomes. Journal of General Internal Medicine 1989, 4:506-511.
11. Taylor TR: Understanding the choices that patients make. Journal of the American Board of Family Practice 2000, 13(2):124-133.
12. Albrecht G and Hoogstraten J: Satisfaction as determination of compliance. Community Dentistry and Oral Epidemiology 1998, 26:139-146.
13. McCracken LM, Klock A and Mingay KA: Assessment of satisfaction with treatment for chronic pain. Journal of Pain and Symptom Management 1997, 14(5):292-299.
14. Weaver M, Patrick DL, Markson LE, Martin D, Frederic I and Berger M: Issues in the measurement of satisfaction with treatment. American Journal of Managed Care 1997, 3(4):579-594.
15. Anderson RB, Hollenberg NK and Williams GH: Physical Symptoms Distress Index: a sensitive tool to evaluate the impact of pharmacological agents on quality of life. Archives of Internal Medicine 1999, 159(7):693-700.
16. Awad AG and Voruganti LN: Quality of life and new antipsychotics in schizophrenia. Are patients better off? International Journal of Social Psychiatry 1999, 45(4):268-275.
17. Diamond R: Drugs and the quality of life: the patient's point of view. Journal of Clinical Psychiatry 1985, 46(5 Pt 2):29-35.
18. Unamed Reference: Adverse effects of the atypical antipsychotics. Collaborative Working Group on Clinical Trial Evaluations. Journal of Clinical Psychiatry 1998, 59(Suppl 12):17-22.
19. Bukstein DA: Incorporating quality of life data into managed care formulary decisions: a case study with salmeterol. American Journal of Managed Care 1997, 3(11):1701-1706.
20. Dunbar-Jacob J, Erlen JA, Schlenk EA, Ryan CM, Sereika SM and Doswell WM: Adherence in chronic disease. Annual Review of Nursing Research 2000, 18:48-90.
21. Strasser S, Aharony L and Greenberger D: The patient satisfaction process: moving toward a comprehensive model. Medical Care Review 1993, 50(2):219-248.
22. Bredart A, Razavi D, Delvaux N, Goodman V, Farvacques C and Van Heer C: A comprehensive assessment of satisfaction with care for cancer patients. Supportive Care in Cancer 1998, 6(6):518-523.
23. Bredart A, Razavi D, Robertson C, Didier F, Scaffidi E, Fonzo D, Autier P and de Haes J: Assessment of quality of care in an oncology institute using information on patients' satisfaction. Oncology 2001, 61(2):120-128.
24. Hudak PL and Wright JG: The characteristics of patient satisfaction measures. Spine 2000, 25(24):3167-3177.
25. Lubeck DP, Litwin MS, Henning JM, Mathias SD, Bloor L and Carroll PR: An instrument to measure patient satisfaction with healthcare in an observational database: results of a validation study using data from CaPSURE. American Journal of Managed Care 2000, 6(1):70-76.
26. Westbrook JI: Patient satisfaction: methodological issues and research findings. Australian Health Review 1993, 16(1):75-88.
27. Gelber RD, Gelman RS and Goldhirsch A: A quality-of-life-oriented endpoint for comparing therapies. Biometrics 1989, 45(3):781-795.
28. Sinha A, Colman SS, Atkinson MJ, Hass SL, Rowland CR, Miller DP and Brod M: The Development of a Conceptual Model for Treatment Satisfaction. Social Science & Medicine (Under Review) .
29. Atkinson MJ, Sinha A, Hass SI, Colman SS and Rowland CR: Validation of General Measure of Treatment Satisfaction, the Treatment Satisfaction Questionnaire for Medications (TSQM), using a National Panel Study of Chronic Disease. Disease Management and Health Outcomes in press.
30. Atkinson MJ and Caldwell L: The differential effects of mood on patients' ratings of life quality and satisfaction with their care: Preliminary findings. The Journal of Affective Disorders 1997, 44:169-175.
31. Atkinson MJ and Violato C: Neuroticism and coping with anger: The trans-situational consistency of coping responses. Personality and Individual Differences 1994, 17:769-782.
32. Morris LA and Miller DW: The regulation of Patient-Reported Outcome claims: Need for a flexible standard. Value in Health 2002, 5:372-381.
33. Linder M, Chang TS, Scott IU, Hay D, Chambers K, Sibley LM and Weis E: Validity of the Visual Function Index (VF-14) in Patients With Retinal Disease. Archives of Ophthalmology 1999, 117(12):1611-1616.
34. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S and Hays RD: for the National Eye Institute Visual Function Questionnaire Field Test Investigators. Development of the 25-Item National Eye Institute Visual Function Questionnaire. Archives of Ophthalmology 2001, 119(7):1050-1058.
35. Margolis MK, Coyne K, Kennedy-Martin T, Baker T, Schein O and Revicki DA: Vision-Specific Instruments for the Assessment of Health-Related Quality of Life and Visual Functioning: A Literature Review. Pharmacoeconomics 2002, 20(12):791-812.
36. D'Ambrosio FA: Assessing disability in the patient with cataracts. Current Opinion in Ophthalmology 1999, 10(1):42-45.
37. Crabtree HL, Hildreth AJ, O'Connell JE, Phelan PS, Allen D and Gray CS: Measuring visual symptoms in British cataract patients: the cataract symptom scale. British Journal of Ophthalmology 1999, 83(5):519-523.
38. Uiters E, van den Borne B, van der Horst F and Volker-Dieben HJM: Patient Satisfaction After Corneal Transplantation. Cornea 2001, 20(7):687-694.
39. Odberg T, Jakobsen JE, Hultgren SJ and Halseide R: The impact of glaucoma on the quality of life of patients in Norway: I. Results from a self-administered questionnaire. Acta Ophthalmologica Scandinavica 2001, 79(2):116-120.
40. Jampel HD, Schwartz A, Pollack I, Abrams D, Weiss H and Miller R: Glaucoma Patients' Assessment of Their Visual Function and Quality of Life. Journal of Glaucoma 2002, 11(2):154-163.
41. Nordmann J, Touboul C, Auzanneau N and Berdeaux G: Vision Related Quality of Life of French Patients is Affected by Topical Glaucoma Treatment Side Effects. Value in Health 2002, 5(6):557-558.
42. Waring George O III: One-year results of European Multicenter Study of Intrastromal Corneal Ring Segments: Part 2: Complications, Visual Symptoms and Patient Satisfaction. Evidence-Based Eye Care 2001, 2(4):222-223.
43. Katz L and Jay MD: Twelve-Month Evaluation of Brimonidine- Purite Versus Brimonidine in Patients With Glaucoma or Ocular Hypertension. Journal of Glaucoma 2002, 11(2):119-126.
44. Asch S, Goldzweig CL and Lee P: Do We Understand the Effects of 'Managed Care' in Ophthalmology?: A Review and Analysis. Archives of Ophthalmology 1997, 115(4):531-536.
45. Barber BL, Strahlman ER, Laibovitz R, Guess HA and Reines SA: Validation of a questionnaire for comparing the tolerability of ophthalmic medications. Ophthalmology 1997, 104(2):334-42. Erratum in: Ophthalmology 1997, 104(5):736, 890-3
46. Stewart WC: Clinical Practice of Glaucoma. Thorofare, N.J.SLACK, Inc 1990.
47. Sheilds MB: Textbook of Glaucoma. 3rd edition. Williams and Wilkins. Baltimore; 1992.
48. Stewart WC: New and current drug therapy for glaucoma. Ciba Clinical Symposium 1997.
49. Stewart WC: Glaucoma Medications and their side effects. Ophthalmic Practice 1999, 17:2.
50. Camras CB, Alm A, Watson P and Stjernschantz J: Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study Groups. Ophthalmology 1996, 103(11):1916-1924.
51. Netland PA, Landry T, Sullivan EK, Andrew R, Silver L, Weiner A, Mallick S, Dickerson J, Bergamini MV, Robertson SM and Davis AA: Travoprost Study Group. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. American Journal of Ophthalmology 2001, 132(4):472-484.
52. Noecker RS, Dirks MS, Choplin NT, Bernstein P, Batoosingh AL, Whitcup SM and Bimatoprost/Latanoprost Study Group: A six- month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma. American Journal of Ophthalmology 2003, 135(1):55-63.
53. Stewart WC and Castelli WP: Systemic side effects of topical beta-adrenergic blockers. Clinical Cardiology 1996, 19:691-697.
54. Stewart WC and Garrison PM: β-blocker-induced complications and the glaucoma patient: newer treatments to help reduce systemic side effects. Archives of Internal Medicine 1998, 158:221-226.
55. Konstas AGP, Papapanos P, Tersis I, Houliara D and Stewart WC: Twenty-four hour diurnal curve comparison of commercially available latanoprost 0.005% versus timolol/dorzolamide fixed combination. Ophthalmology 2003 in press.
56. Stewart WC, Stewart JA and Leech JN: Acute and chronic ocular symptoms of dorzolamide 2% compared with placebo. Journal of Glaucoma 2003, 12(2):151-155.
57. Stewart WC, Sharpe ED, Harbin TS Jr, Pastor SA, Day DG, Holmes KT and Stewart JA: Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure. American Journal of Ophthalmology 2000, 129(6):723-727.
58. LeBlanc RP: Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension. Brimonidine Study Group 2. Ophthalmology 1998, 105(10):1960-1967.
59. Goldman AE: The Group Depth Interview. Principles and Practice- Prentice-Hall, Inc. A division of Simon & Schuster. Englewood Cliffs, New Jersey; 1987.
60. Tabachnick BG and Fidell LS: Using Multivariate Statistics 4th edition. Boston: Allyn and Bacon; 2001.
61. Hays RD, Anderson R and Revicki D: Psychometric considerations in evaluating health-related quality of life measures. Quality of Life Research 1993, 2:441-449.
62. Ware J and Hays RD: Methods for measuring patient satisfaction with specific medical encounters. Medical Care 1988, 26:393-402.
63. Juniper EF: Intrepreting of Quality of Life data. Quality of Life Newsletter 1999.